Trial intelligence / Profile preview

Dexmedetomidine plus ropivacaine for epidural labor analgesia

ChiCTR2200061040Phase 4Recruiting

Sponsor
Jiashan First People's Hospital
Start
Jun 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine and ropivacaine in labor pain (5 arms), sponsored by Jiashan First People's Hospital. Primary endpoint: VAS score for labor pain. Started Jun 2022; status: recruiting.

02

Drugs

dexmedetomidineropivacaine
03

Conditions

labor pain

Beyond the preview

Go deeper on ChiCTR2200061040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200061040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call